Additional file 1 of The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study

Additional file 1: Table S1 International Classification of Diseases (10th edition) Clinical Modification (ICD 10-CM) codes used to define comorbidities and clinical outcomes in this study.